EcoDrugPlus

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSAPOG00000021147
Gene Symbol: LOC110964282
3 Cross references
215 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSAPOG00000001576
Gene Symbol: LOC110967717
3 Cross references
230 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSAPOG00000009955
Gene Symbol: SLC18A2
3 Cross references
216 Possible Orthologues:

Solute Carrier Family 22 Member 6-Like

Ensembl ID : ENSAPOG00000008331
Gene Symbol: LOC110948799
3 Cross references
360 Possible Orthologues:

Solute Carrier Family 29 Member 1 (Augustine Blood Group)

Ensembl ID : ENSAPOG00000017341
Gene Symbol: SLC29A1
3 Cross references
207 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSAPOG00000023512
Gene Symbol: SLC6A2
3 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSAPOG00000022859
Gene Symbol: SLC6A3
3 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSAPOG00000009838
Gene Symbol: SLC6A9
3 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSAPOG00000014354
Gene Symbol: SLC9A3
3 Cross references
235 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSAPOG00000014118
Gene Symbol: SLC9A3
3 Cross references
235 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSAPOG00000017252
Gene Symbol: SLC9A3
4 Cross references
235 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSAPOG00000007870
Gene Symbol: SSTR1
1 Cross references
160 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).